All Stories

  1. The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer

    Article • Molecular Biology Reports, January 2024, Springer Science + Business Media

    PhD LUCIA TAJA-CHAYEB

  2. NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review

    Article • PLOS One, April 2023, PLOS

    PhD LUCIA TAJA-CHAYEB

  3. BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal

    Article • Current Molecular Pharmacologye, October 2022, Bentham Science Publishers

    PhD LUCIA TAJA-CHAYEB

  4. ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma

    Article • Cancers, September 2022, MDPI AG

    PhD LUCIA TAJA-CHAYEB

  5. Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications

    Article • Current Cancer Drug Targets, August 2022, Bentham Science Publishers

    PhD LUCIA TAJA-CHAYEB

  6. Hereditary gastric cancer literature review

    Article • Clinics and Research in Hepatology and Gastroenterology, April 2022, Elsevier

    PhD LUCIA TAJA-CHAYEB

  7. A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell Lymphoma

    Article • Revista de Investigación Clínica, November 2021, Publicidad Permanyer, SLU

    PhD LUCIA TAJA-CHAYEB

  8. Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient

    Article • Boletín Médico del Hospital Infantil de México, May 2021, Publicidad Permanyer, SLU

    PhD LUCIA TAJA-CHAYEB

  9. Analysis of the CAG tract length in the Androgen Receptor gene in Mexican patients with nonsyndromic cryptorchidism

    Article • Journal of Pediatric Endocrinology and Metabolism, April 2021, De Gruyter

    PhD LUCIA TAJA-CHAYEB

  10. The role of extracellular DNA (exDNA) in cellular processes

    Article • Cancer Biology & Therapy, April 2021, Taylor & Francis

    PhD LUCIA TAJA-CHAYEB

  11. Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma

    Article • Cellular and Molecular Neurobiology, June 2020, Springer Science + Business Media

    PhD LUCIA TAJA-CHAYEB

  12. Investigation of HER-2 status, treatment response and survival analysis in cervical cancer patients

    Article • European Journal of Gynaecological Oncology, January 2020, MRE Press

    PhD LUCIA TAJA-CHAYEB

  13. High-Dose Methotrexate, A Tried-and-True Treatment with Genomic Delicacies: A Case Report

    Article • January 2020, Annals of Clinical and Medical Case Reports

    PhD LUCIA TAJA-CHAYEB

  14. A combination of inhibitors of glycolysis, glutaminolysis and de�novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells

    Article • Oncology Letters, October 2019, Spandidos Publications

    PhD LUCIA TAJA-CHAYEB

  15. Growth inhibition and transcriptional effects of ribavirin in lymphoma

    Article • Oncology Reports, July 2019, Spandidos Publications

    PhD LUCIA TAJA-CHAYEB

  16. Epigenetic treatment of metastasis with hydralazine and valproic acid

    Article • OncoTargets and Therapy, December 2018, Dove Medical Press

    Enrique Pérez-Cárdenas, PhD LUCIA TAJA-CHAYEB, Dr Elizabeth Langley

  17. Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma

    Article • PLOS One, November 2018, PLOS

    PhD LUCIA TAJA-CHAYEB

  18. Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy

    Article • Expert Opinion on Investigational Drugs, May 2018, Taylor & Francis

    Enrique Pérez-Cárdenas, PhD LUCIA TAJA-CHAYEB

  19. Características ultrasonográficas, histopatológicas y genéticas del melanoma uveal en población mexicana mestiza ☆

    Article • Archivos de la Sociedad Española de Oftalmología, January 2018, Elsevier

    PhD LUCIA TAJA-CHAYEB

  20. Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening

    Article • Molecular and Cellular Probes, October 2017, Elsevier

    PhD LUCIA TAJA-CHAYEB

  21. Single nucleotide polymorphisms associated with nonsyndromic cryptorchidism in Mexican patients

    Article • Andrologia, March 2017, Hindawi Publishing Corporation

    PhD LUCIA TAJA-CHAYEB

  22. Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer

    Article • Oncology Letters, January 2017, Spandidos Publications

    PhD LUCIA TAJA-CHAYEB

  23. Antitumor Effects of Systemic DNAse I and Proteases in an In Vivo Model

    Article • Integrative Cancer Therapies, July 2016, SAGE Publications

    PhD LUCIA TAJA-CHAYEB

  24. Viral inhibitors of NKG2D ligands for tumor surveillance

    Article • Expert Opinion on Therapeutic Targets, June 2016, Taylor & Francis

    PhD LUCIA TAJA-CHAYEB

  25. Ribavirin as a tri-targeted antitumor repositioned drug

    Article • Oncology Reports, February 2015, Spandidos Publications

    PhD LUCIA TAJA-CHAYEB

  26. DNA methyltransferases 3a and 3b are differentially expressed in the early stages of a rat liver carcinogenesis model

    Article • Oncology Reports, September 2014, Spandidos Publications

    PhD LUCIA TAJA-CHAYEB

  27. Hydralazine–valproate: a repositioned drug combination for the epigenetic therapy of cancer

    Article • Expert Opinion on Drug Metabolism & Toxicology, August 2014, Informa Healthcare

    PhD LUCIA TAJA-CHAYEB

  28. The reduction of Calpain-10 expression is associated with risk polymorphisms in obese children

    Article • Gene, March 2013, Elsevier

    PhD LUCIA TAJA-CHAYEB

  29. Neuroendocrine Marker Expression in Cervical Carcinomas of Non-Small Cell Type

    Article • International Journal of Gynecological Pathology, October 2002, Wolters Kluwer Health

    PhD LUCIA TAJA-CHAYEB